Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions
Anesthesia
Interventions
DRUG

Rocuronium 0.6 mg/kg intubating dose

Rocuronium 0.6 mg/kg intubating dose

DRUG

Rocuronium 0.9 mg/kg intubating dose

0.9 mg/kg intubating dose of rocuronium

DRUG

Rocuronium 0.1 mg/kg maintenance dose

Rocuronium 0.1 mg/kg maintenance dose following the intubating dose.

DRUG

Rocuronium 0.15 mg/kg maintenance dose

Rocuronium 0.15 mg/kg maintenance dose following the intubating dose

DRUG

Rocuronium 0.2 mg/kg maintenance

Rocuronium 0.2 mg/kg maintenance dose following the intubating dose

DRUG

Vecuronium 0.1 mg/kg intubating dose

Vecuronium 0.1 mg/kg intubating dose

DRUG

Vecuronium 0.025 mg/kg maintenance dose

Vecuronium 0.025 mg/kg maintenance dose following the intubating dose

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00970762 - Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED) | Biotech Hunter | Biotech Hunter